Evidence map›Paper›PMID 34461875›Full record

ArticleBMC musculoskeletal disorders2021

The ideal mHealth-application for rheumatoid arthritis: qualitative findings from stakeholder focus groups.

Michaël Doumen, René Westhovens, Sofia Pazmino, Delphine Bertrand, Veerle Stouten, Claudia Neys, Nelly Creten, Els Van Laeken, Patrick Verschueren, Diederik De Cock

Registry-linked trialAbstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05888181 (Effectiveness and Feasibility of a Mobile Health Self-management Intervention for Patients With Rheumatoid Arthritis), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05888181 nacompletednot on this mapstarted 2023, after this paper: background citation

Effectiveness and Feasibility of a Mobile Health Self-management Intervention for Patients With Rheumatoid Arthritis: the App-based Education and GOal-setting in Rheumatoid Arthritis Trial

TypeinterventionalSponsorUniversitaire Ziekenhuizen KU LeuvenRan2023 to 2024Enrolled128ConditionsRheumatoid ArthritisArmsMobile app-based self-management intervention
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Michaël DoumenSkeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium. michael.doumen@kuleuven.be.ORCID http://orcid.org/0000-0001-6073-7635
René WesthovensSkeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium.
Sofia PazminoSkeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium.
Delphine BertrandSkeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium.
Veerle StoutenSkeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium.
Claudia NeysPatient Experts Rheumatology, ReumaNet, Leuven, Belgium.
Nelly CretenPatient Experts Rheumatology, ReumaNet, Leuven, Belgium.
Els Van LaekenPatient Experts Rheumatology, ReumaNet, Leuven, Belgium.
Patrick VerschuerenSkeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium.
Diederik De CockSkeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium.

Funding

Fonds Wetenschappelijk Onderzoek 1S85521N
6 · The paper itself

Abstract

backgroundShifts in treatment strategies for rheumatoid arthritis (RA) have made ambulatory care more labour-intensive. These developments have prompted innovative care models, including mobile health (mHealth) applications. This study aimed to explore the perceptions of mHealth-inexperienced stakeholders concerning these applications in RA care.

methodsWe performed a qualitative study by focus group interviews of stakeholders including RA patients, nurses specialised in RA care and rheumatologists. The qualitative analysis guide of Leuven (QUAGOL), which is based on grounded theory principles, was used to thematically analyse the data. In addition, the Persuasive Systems Design (PSD) model was used to structure recommended app-features.

resultsIn total, 2 focus groups with nurses (total n = 16), 2 with patients (n = 17) and 2 with rheumatologists (n = 25) took place. Six overarching themes emerged from the analysis. Efficiency of care and enabling patient empowerment were the two themes considered as expected benefits of mHealth-use in practice by the stakeholders. In contrast, 4 themes emerged as possible barriers of mHealth-use: the burden of chronic app-use, motivational aspects, target group aspects, and legal and organisational requirements. Additionally, recommendations for an ideal mHealth-app could be structured into 4 domains (Primary Task Support, Dialogue Support, Social Support and System Credibility) according to the PSD-framework. Most recommended features were related to improving ease of use (Task Support) and System Credibility.

conclusionsAlthough mHealth-apps were expected to improve care efficiency and stimulate patient empowerment, stakeholders were concerned that mHealth-app use could reinforce negative illness behaviour. For mHealth-apps to be successful in practice, challenges according to stakeholders were avoiding long-term poor compliance, finding the target audience and tailoring a legal and organisational framework. Finally, the ideal mHealth-application should above all be trustworthy and easy to use.

Indexed as

Arthritis, RheumatoidMobile ApplicationsTelemedicineFocus GroupsHumansQualitative ResearchCare innovationseHealthFocus groupsmHealthMobile appsPerceptionsQualitativeRheumatoid arthritisStakeholders

Identifiers

PMID34461875
PMCPMC8406841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.